• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

AllianzGI Wellness Fund

+ Add to Watchlist

RAGHX:US

36.90 USD 0.04 0.11%

As of 09:29:30 ET on 11/21/2014.

Snapshot for AllianzGI Wellness Fund (RAGHX)

Year To Date: +23.33% 3-Month: +3.86% 3-Year: +27.17% 52-Week Range: 28.66 - 37.28
1-Month: +4.77% 1-Year: +27.84% 5-Year: +18.83% Beta vs MXWO0HC: 1.09

Mutual Fund Chart for RAGHX

No chart data available.
  • RAGHX:US 36.90
  • 1M
  • 1Y
Interactive RAGHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RAGHX

AllianzGI Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invests in the equity securities of health care companies of any size located in at least three different countries, which may include the United States.

Inception Date: 02-05-2002 Telephone: 1-888-852-3922
Managers: MICHAEL DAUCHOT / JOHN SCHROER
Web Site: www.allianzinvestors.com

Fundamentals for RAGHX

NAV (on 2014-11-21) 36.90
Assets (M) (on 2014-10-31) 179.70
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for RAGHX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-12) 1.93
Dividend Yield (ttm) 16.48

Fees & Expenses for RAGHX

Front Load 5.50
Back Load 1.00
Current Mgmt Fee 0.80
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.46

Top Fund Holdings for RAGHX

Filing Date: 08/31/2014
Name Position Value % of Total
Johnson & Johnson 81,555 8,459,700 4.902%
Gilead Sciences Inc 71,170 7,656,469 4.436%
Actavis plc 32,470 7,370,041 4.270%
Roche Holding AG 23,400 6,834,155 3.960%
Shire PLC 80,025 6,520,223 3.778%
HCA Holdings Inc 83,315 5,817,053 3.371%
Celgene Corp 57,270 5,441,795 3.153%
Puma Biotechnology Inc 20,520 5,345,665 3.097%
Salix Pharmaceuticals Ltd 32,400 5,155,164 2.987%
Boston Scientific Corp 387,950 4,919,206 2.850%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil